Alkermes (ALKS) News Today → The biggest energy story ever? (From Porter & Company) (Ad) Free ALKS Stock Alerts $24.01 -0.53 (-2.16%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineALKS Stock Earnings: Alkermes Misses EPS, Misses Revenue for Q1 2024investorplace.com - May 1 at 1:02 PMAlkermes plc Q1 Earnings Summarymarkets.businessinsider.com - May 1 at 10:06 AMAlkermes (NASDAQ:ALKS) Updates FY 2024 Earnings Guidancemarketbeat.com - May 1 at 9:52 AMAlkermes plc Reports First Quarter 2024 Financial Resultsprnewswire.com - May 1 at 7:00 AMYousif Capital Management LLC Takes Position in Alkermes plc (NASDAQ:ALKS)marketbeat.com - May 1 at 5:38 AMAlkermes plc (NASDAQ:ALKS) Short Interest Updateamericanbankingnews.com - April 30 at 6:22 AMAlkermes plc (NASDAQ:ALKS) Receives Average Recommendation of "Moderate Buy" from Analystsamericanbankingnews.com - April 30 at 2:18 AMAlkermes plc (NASDAQ:ALKS) Receives Consensus Rating of "Moderate Buy" from Analystsmarketbeat.com - April 30 at 2:17 AMAlkermes Stock (NASDAQ:ALKS), Quotes and News Summarybenzinga.com - April 30 at 12:13 AMAlkermes (ALKS) Set to Announce Quarterly Earnings on Wednesdayamericanbankingnews.com - April 29 at 6:30 AMSector Gamma AS Invests $5.55 Million in Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 27 at 4:38 PMAlkermes plc (NASDAQ:ALKS) Shares Acquired by Handelsbanken Fonder ABmarketbeat.com - April 26 at 6:39 AMAlkermes Announces Initiation of Vibrance-1 Phase 2 Study Evaluating ALKS 2680 for the Treatment of Narcolepsy Type 1finance.yahoo.com - April 24 at 8:44 AMAlkermes (NASDAQ:ALKS) Stock Rating Reaffirmed by HC Wainwrightamericanbankingnews.com - April 21 at 4:36 AMAlkermes (NASDAQ:ALKS) Given "Neutral" Rating at HC Wainwrightmarketbeat.com - April 19 at 8:19 AMMutual of America Capital Management LLC Has $3.33 Million Position in Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 18 at 5:31 AMAlkermes to Report First Quarter Financial Results on May 1, 2024prnewswire.com - April 17 at 4:00 PMAlkermes (NASDAQ:ALKS) Shares Up 2.9%marketbeat.com - April 17 at 2:15 PMAlkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q1 Releasefinance.yahoo.com - April 17 at 1:06 PMLouisiana State Employees Retirement System Invests $2.32 Million in Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 17 at 6:00 AMHardman Johnston Global Advisors LLC Sells 131,809 Shares of Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 12 at 9:29 PMHold Rating on Alkermes Amid Promising ALKS 2680 Data and Regulatory Challengesmarkets.businessinsider.com - April 12 at 7:09 AMQ3 2025 Earnings Forecast for Alkermes plc Issued By Zacks Research (NASDAQ:ALKS)marketbeat.com - April 12 at 6:40 AMJefferies raises Alkermes stock target on positive OX2 datainvesting.com - April 11 at 9:08 PMFY2027 EPS Estimates for Alkermes plc (NASDAQ:ALKS) Decreased by Leerink Partnrsmarketbeat.com - April 11 at 7:58 AMBuy Rating Affirmed for Alkermes on Promising ALKS 2680 Clinical Trial Results and Growth Potentialmarkets.businessinsider.com - April 10 at 7:22 AMBreaking Down Alkermes: 5 Analysts Share Their Viewsmarkets.businessinsider.com - April 9 at 5:54 PMAlkermes posts early-stage win for sleeping disorder therapy (update)msn.com - April 9 at 5:54 PMAlkermes: Waking Up Narcolepsy Treatment With Promising Trial Dataseekingalpha.com - April 9 at 5:54 PMAlkermes succeeds in early-stage trial for sleeping disorder therapymsn.com - April 9 at 12:53 PMAlkermes (NASDAQ:ALKS) PT Raised to $50.00marketbeat.com - April 9 at 12:12 PMAlkermes (NASDAQ:ALKS) Shares Gap Up to $25.93marketbeat.com - April 9 at 10:57 AMAlkermes plc: Collecting The Fruits Of The 2023 Spinoffseekingalpha.com - April 9 at 9:49 AMAlkermes Announces Positive Topline Results From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 2 and Idiopathic Hypersomniaprnewswire.com - April 9 at 7:00 AMAlkermes Presents Analyses From Long-Term Safety Study of LYBALVI® (olanzapine and samidorphan) at 2024 Congress of the Schizophrenia International Research Societyprnewswire.com - April 8 at 7:00 AMAssenagon Asset Management S.A. Buys New Shares in Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 5 at 4:28 AMState of Alaska Department of Revenue Takes $2.85 Million Position in Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 4 at 4:49 AMRedwood Investments LLC Sells 319,609 Shares of Alkermes plc (NASDAQ:ALKS)marketbeat.com - April 1 at 6:48 AMSG Americas Securities LLC Sells 97,624 Shares of Alkermes plc (NASDAQ:ALKS)marketbeat.com - March 31 at 4:15 AMInvestors in Alkermes (NASDAQ:ALKS) have seen favorable returns of 44% over the past three yearsfinance.yahoo.com - March 29 at 11:04 AMNoteworthy Tuesday Option Activity: ALKS, DKNG, VRTnasdaq.com - March 28 at 2:59 PMVanguard Group Inc. Acquires 72,797 Shares of Alkermes plc (NASDAQ:ALKS)marketbeat.com - March 24 at 4:30 AMAlkermes exec sells over $290k in company sharesinvesting.com - March 20 at 4:26 PMAmerican Century Companies Inc. Raises Stock Holdings in Alkermes plc (NASDAQ:ALKS)marketbeat.com - March 20 at 4:32 AMBaird starts Alkermes at outperform, citing revenue streammsn.com - March 19 at 3:11 PMThe Analyst Verdict: Alkermes In The Eyes Of 4 Expertsmarkets.businessinsider.com - March 19 at 10:10 AMAlkermes (NASDAQ:ALKS) Receives New Coverage from Analysts at Robert W. Bairdmarketbeat.com - March 19 at 8:46 AMAlkermes plc (NASDAQ:ALKS) SVP Sells $292,717.70 in Stockinsidertrades.com - March 19 at 5:01 AMInsider Sell: SVP, Chief Commercial Officer Christian Nichols Sells Shares of Alkermes PLC (ALKS)finance.yahoo.com - March 18 at 7:06 PMInsider Selling: Alkermes plc (NASDAQ:ALKS) SVP Sells 10,417 Shares of Stockmarketbeat.com - March 18 at 5:16 PM Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Email Address The biggest energy story ever? (Ad)Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie… For the full story, click here. ALKS Media Mentions By Week ALKS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALKS News Sentiment▼1.100.34▲Average Medical News Sentiment ALKS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALKS Articles This Week▼156▲ALKS Articles Average Week Get Alkermes News Delivered to You Automatically Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Madrigal Pharmaceuticals News Amicus Therapeutics News Ionis Pharmaceuticals News Geron News Agios Pharmaceuticals News Dynavax Technologies News Ironwood Pharmaceuticals News Pacira BioSciences News Ligand Pharmaceuticals News MannKind News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALKS) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingForget Nvidia. This is the future of AIPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alkermes plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
